Immunohistochemical demonstration of substance P in the lower respiratory tract of the rabbit and not of man.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 459601)

Published in Thorax on July 01, 1983

Authors

L A Laitinen, A Laitinen, P A Panula, M Partanen, K Tervo, T Tervo

Articles cited by this

The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem (1970) 20.22

Purinergic nerves. Pharmacol Rev (1972) 12.05

An unidentified depressor substance in certain tissue extracts. J Physiol (1931) 5.19

[Central transmission of afferent impulses. III. Incidence and significance of the substance P in the dorsal roots of the spinal cord]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1953) 3.03

Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res (1975) 2.72

Detection of substance P in the central nervous system by a monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.16

Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol (1976) 2.09

Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways. Science (1980) 2.01

Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res (1981) 1.74

Release of histamine by substance P. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.56

Auerbach's plexus of mammals and man: electron microscopic identification of three different types of neuronal processes in myenteric ganglia of the large intestine from rhesus monkeys, guinea-pigs and man. Z Zellforsch Mikrosk Anat (1970) 1.33

Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat. Nature (1976) 1.25

Substance P in the vagus nerve. Immunochemical and immunohistochemical evidence for axoplasmic transport. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.23

Noncholinergic, nonadrenergic contraction and substance P in rabbit iris sphincter muscle. Jpn J Pharmacol (1981) 0.98

Peptide containing nerves in the nasal mucosa. Rhinology (1981) 0.89

Substance P-immunoreactive nerves in the human cornea and iris. Invest Ophthalmol Vis Sci (1982) 0.89

Demonstration of enkephalin-, substance P- and glutamate decarboxylase-like immunoreactivity in cultured cells derived from newborn rat neostriatum. Histochemistry (1980) 0.80

Articles by these authors

Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am Rev Respir Dis (1976) 6.26

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med (1999) 4.65

Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis (1985) 4.59

Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12

Asthma programme in Finland: a community problem needs community solutions. Thorax (2001) 2.68

Prevalence of asthma in Finnish young men. BMJ (1990) 2.20

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol (1992) 2.16

A 10 year asthma programme in Finland: major change for the better. Thorax (2006) 2.13

Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet (1993) 1.98

Genetic control of serum IgE levels and asthma: linkage and linkage disequilibrium studies in an isolated population. Hum Mol Genet (1997) 1.82

Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis (1993) 1.73

European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J (1992) 1.47

Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects. Eur Respir J (1991) 1.45

Corneal stromal changes induced by myopic LASIK. Invest Ophthalmol Vis Sci (2000) 1.43

Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med (1997) 1.39

Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis (1993) 1.39

Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. Eur J Clin Pharmacol (1979) 1.37

A susceptibility locus for asthma-related traits on chromosome 7 revealed by genome-wide scan in a founder population. Nat Genet (2001) 1.36

Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J (2006) 1.34

Does non-responder bias have a significant effect on the results in a postal questionnaire study? Eur J Epidemiol (2001) 1.31

Catecholamine- and acetylcholinesterase-containing nerves in human lower respiratory tract. Histochemistry (1982) 1.27

Perinatal risk factors for asthma in Finnish adolescent twins. Thorax (2000) 1.25

Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med (2000) 1.23

Seasonal variability of exercise-induced asthma especially outdoors. Effect of birch pollen allergy. Clin Exp Allergy (1989) 1.22

Incidence and prevalence of asthma among adult Finnish men and women of the Finnish Twin Cohort from 1975 to 1990, and their relation to hay fever and chronic bronchitis. Chest (1999) 1.19

Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res (2000) 1.18

Importance of genetic factors in adolescent asthma: a population-based twin-family study. Am J Respir Crit Care Med (1998) 1.18

Sleep-related disordered breathing during pregnancy in obese women. Chest (2001) 1.17

Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun (1984) 1.15

Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol (1989) 1.14

VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopic study. Histochemistry (1985) 1.12

The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology (2000) 1.08

Differential expression of laminins and their integrin receptors in developing and adult human lung. Am J Respir Cell Mol Biol (1996) 1.08

Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med (2005) 1.07

Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res (1997) 1.07

Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med (1999) 1.06

Electron microscopic study on the innervation of the human lower respiratory tract: evidence of adrenergic nerves. Eur J Respir Dis (1985) 1.02

Social predictors of adult asthma: a co-twin case-control study. Thorax (2001) 1.01

Increased release of tumour necrosis factor-alpha in human tear fluid after excimer laser induced corneal wound. Br J Ophthalmol (1997) 1.01

Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg (1975) 1.01

Biopsy markers of airway inflammation and remodelling. Respir Med (2000) 1.00

Relationship between tracheal mucosal thickness and vascular resistance in dogs. J Appl Physiol (1985) (1986) 1.00

Effects of oleoresin capsicum pepper spray on human corneal morphology and sensitivity. Invest Ophthalmol Vis Sci (2000) 0.99

Real-time confocal microscopic observations on human corneal nerves and wound healing after excimer laser photorefractive keratectomy. Curr Eye Res (1997) 0.99

Histamine and metacholine challenge in the testing of bronchial reactivity. Scand J Respir Dis Suppl (1974) 0.99

Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol (1996) 0.98

Effects of inflammatory and other mediators on airway vascular beds. Am Rev Respir Dis (1987) 0.97

Effect of sensory and sympathetic denervation on substance P immunoreactivity in nerve fibres of the rabbit eye. Exp Eye Res (1982) 0.97

Hay fever, asthma and number of older siblings--a twin study. Clin Exp Allergy (1997) 0.97

Asthma, allergy and bronchial hyper-reactivity to histamine in patients with bronchiectasis. Clin Allergy (1978) 0.96

Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid. Am Rev Respir Dis (1991) 0.96

Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Ophthalmol (Copenh) (1987) 0.95

Expression of tenascin and cellular fibronectin in the rabbit cornea after anterior keratectomy. Immunohistochemical study of wound healing dynamics. Invest Ophthalmol Vis Sci (1991) 0.94

Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol (1996) 0.94

Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med (2002) 0.94

The distribution and endocrine nature of the abdominal paraganglia of adult man. Am J Anat (1978) 0.93

Airway morphology: epithelium/basement membrane. Am J Respir Crit Care Med (1994) 0.92

Expression of cellular fibronectin and tenascin in the rabbit cornea after excimer laser photorefractive keratectomy: a 12 month study. Br J Ophthalmol (1995) 0.91

Effect of strenuous physical stress on circulating lymphocyte number and function before and after training. J Clin Lab Immunol (1982) 0.91

Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. Respir Med (2002) 0.91

Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J (2000) 0.91

Immunoreactivity for substance P in the Gasserian ganglion, ophthalmic nerve and anterior segment of the rabbit eye. Histochem J (1981) 0.91

Platelet-derived growth factor-BB (PDGF-BB) in tear fluid: a potential modulator of corneal wound healing following photorefractive keratectomy. Curr Eye Res (1997) 0.91

In vivo confocal microscopy: a new possibility to confirm the diagnosis of Borrelia keratitis? Cornea (1996) 0.90

Characterization of cell-specific modulatory element in the murine ornithine decarboxylase promoter. Biochem J (1996) 0.90

Bronchial hyperreactivity to inhaled histamine in patients with farmer's lung. Lung (1981) 0.90

Effects of intravenous histamine on static lung compliance and airway resistance in normal man. Am Rev Respir Dis (1976) 0.90

Association study of 15 novel single-nucleotide polymorphisms of the T-bet locus among Finnish asthma families. Clin Exp Allergy (2004) 0.90

Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations. Acta Ophthalmol Suppl (1992) 0.90

Corneal wound healing and nerve morphology after excimer laser in situ keratomileusis in human eyes. J Refract Surg (1997) 0.90

Postoperative inflammation, microbial complications, and wound healing following laser in situ keratomileusis. J Refract Surg (2001) 0.90

Increase of asthma in adults in northern Finland?--a report from the FinEsS study. Allergy (2001) 0.89

Substance P-immunoreactive nerves in the human cornea and iris. Invest Ophthalmol Vis Sci (1982) 0.89

Non-specific bronchial reactivity and ultrastructure of the airway epithelium in patients with sarcoidosis and allergic alveolitis. Eur J Respir Dis Suppl (1983) 0.89

Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respir Med (2003) 0.89

Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment. Thorax (2003) 0.89

Histochemical evidence of limited reinnervation of human corneal grafts. Acta Ophthalmol (Copenh) (1985) 0.89

The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies. Respir Med (1998) 0.89

A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. Genomics (2001) 0.88